These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome]. Allerberger F; Sölder B; Caprioli A; Karch H Wien Klin Wochenschr; 1997 Sep; 109(17):669-77. PubMed ID: 9381722 [TBL] [Abstract][Full Text] [Related]
48. Sequence of glomerular changes in experimental endotoxemia: a possible model of hemolytic uremic syndrome. Bertani T; Abbate M; Zoja C; Corna D; Remuzzi G Nephron; 1989; 53(4):330-7. PubMed ID: 2601800 [TBL] [Abstract][Full Text] [Related]
49. Cerebrovascular damage in young rabbits after intravenous administration of Shiga toxin 2. Mizuguchi M; Sugatani J; Maeda T; Momoi T; Arima K; Takashima S; Takeda T; Miwa M Acta Neuropathol; 2001 Oct; 102(4):306-12. PubMed ID: 11603804 [TBL] [Abstract][Full Text] [Related]
50. Successful steroid pulse therapy for brain lesion caused by Shiga toxin 2 in rabbits. Fujii J; Kinoshita Y; Matsukawa A; Villanueva SY; Yutsudo T; Yoshida S Microb Pathog; 2009 Apr; 46(4):179-84. PubMed ID: 19490831 [TBL] [Abstract][Full Text] [Related]
51. Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system. Mizuguchi M; Tanaka S; Fujii I; Tanizawa H; Suzuki Y; Igarashi T; Yamanaka T; Takeda T; Miwa M Acta Neuropathol; 1996; 91(3):254-62. PubMed ID: 8834537 [TBL] [Abstract][Full Text] [Related]
52. A role for hemolysin in Escherichia coli-induced inflammation in granulocytopenic rabbits. Issekutz AC; Ripley M; Rochon Y; Pi-Jimenez E; Wright B J Infect Dis; 1984 Dec; 150(6):925-34. PubMed ID: 6389720 [TBL] [Abstract][Full Text] [Related]
53. Kinetics of acute inflammation induced by E coli in rabbits. Quantitation of blood flow, enhanced vascular permeability, hemorrhage, and leukocyte accumulation. Kopaniak MM; Issekutz AC; Movat HZ Am J Pathol; 1980 Feb; 98(2):485-98. PubMed ID: 6986785 [TBL] [Abstract][Full Text] [Related]
54. Shiga Toxins: An Update on Host Factors and Biomedical Applications. Liu Y; Tian S; Thaker H; Dong M Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852 [TBL] [Abstract][Full Text] [Related]
55. A One Health Perspective for Defining and Deciphering García A; Fox JG Comp Med; 2021 Feb; 71(1):3-45. PubMed ID: 33419487 [No Abstract] [Full Text] [Related]
56. Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease. Dennhardt S; Pirschel W; Wissuwa B; Daniel C; Gunzer F; Lindig S; Medyukhina A; Kiehntopf M; Rudolph WW; Zipfel PF; Gunzer M; Figge MT; Amann K; Coldewey SM Front Immunol; 2018; 9():1459. PubMed ID: 29988557 [TBL] [Abstract][Full Text] [Related]
57. Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neurons. Obata F; Hippler LM; Saha P; Jandhyala DM; Latinovic OS Front Mol Neurosci; 2015; 8():30. PubMed ID: 26236186 [TBL] [Abstract][Full Text] [Related]
58. Role of Shiga/Vero toxins in pathogenesis. Obata F; Obrig T Microbiol Spectr; 2014 Jun; 2(3):. PubMed ID: 25530918 [TBL] [Abstract][Full Text] [Related]
59. Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib. Stone SM; Thorpe CM; Ahluwalia A; Rogers AB; Obata F; Vozenilek A; Kolling GL; Kane AV; Magun BE; Jandhyala DM Front Cell Infect Microbiol; 2012; 2():135. PubMed ID: 23162799 [TBL] [Abstract][Full Text] [Related]